Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms

Abstract

Alzheimer's disease (AD) is the most common cause of dementia and a progressive neurodegeneration that appears to result from multiple pathogenic mechanisms (including protein misfolding/aggregation, involved in both amyloid β-dependent senile plaques and tau-dependent neurofibrillary tangles), metabolic and mitochondrial dysfunction, excitoxicity, calcium handling impairment, glial cell dysfunction, neuroinflammation, and oxidative stress. Oxidative stress, which could be secondary to several of the other pathophysiological mechanisms, appears to be a major determinant of the pathogenesis and progression of AD. The identification of oxidized proteins common for mild cognitive impairment and AD suggests that key oxidation pathways are triggered early and are involved in the initial progression of the neurodegenerative process. Abundant data support that oxidative stress, also considered as a main factor for aging, the major risk factor for AD, can be a common key element capable of articulating the divergent nature of the proposed pathogenic factors. Pathogenic mechanisms influence each other at different levels. Evidence suggests that it will be difficult to define a single-target therapy resulting in the arrest of progression or the improvement of AD deterioration. Since oxidative stress is present from early stages of disease, it appears as one of the main targets to be included in a clinical trial. Exploring the articulation of AD pathogenic mechanisms by oxidative stress will provide clues for better understanding the pathogenesis and progression of this dementing disorder and for the development of effective therapies to treat this disease.

Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response

“…ROS are widely recognized to be key mediators of cell survival, proliferation, differentiation and apoptosis (5,13,14). Previous studies have demonstrated that proteins of the Bcl-2 family, including Bax and Bcl-2, are associated with apoptosis induced by ROS-generating agents (Ji BS,Renaud,Pan).…”

Reactive Oxygen and Nitrogen Species in Steatotic Hepatocytes: A Molecular Perspective on the Pathophysiology of Ischemia-Reperfusion Injury in the Fatty Liver

“…Irrespective of the cause, the propensity for ONS is especially pronounced when endogenous repair mechanisms fail to clear oxidized and nitrated biomolecules (74). Over the years, ONS has been recognized as a key contributor to a variety of pathologies, including those affecting the brain (212), heart (167), vasculature (67), and liver.…”

Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

“…One of the major effects of nanoparticles in the treatment of AD is their potential ability to inhibit the protein fibrillization process, which is an important step in the pathogenesis of AD. 8 Recent results have confirmed not only that molecular events could cause the fibrillization but also that a number of intermediate oligomeric states of different association numbers and structures could interfere with the fibrillization process. 8 The use of some agents that interfere with these processes can help to elucidate the molecular mechanism of fibril formation whilst some strategies could also have therapeutic potential for the treatment of amyloidosis.…”

“…8 Recent results have confirmed not only that molecular events could cause the fibrillization but also that a number of intermediate oligomeric states of different association numbers and structures could interfere with the fibrillization process. 8 The use of some agents that interfere with these processes can help to elucidate the molecular mechanism of fibril formation whilst some strategies could also have therapeutic potential for the treatment of amyloidosis. In this case, nanoparticles can have a significant effect on the fibrillization of proteins; for instance, the presence of nanoparticles could lead to a shortening of the lag phase for nucleation of the fibrillization process.…”